Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Lipid bilayer membrane lipids are the fundamental structural components of all biological membranes, primarily composed of phospholipids, sphingolipids, and sterols (Source: Nature Reviews Molecular Cell Biology). These lipids form a semi-permeable barrier that defines cellular boundaries and compartmentalizes intracellular organelles. Beyond their structural role, membrane lipids are dynamic participants in signal transduction, acting as precursors for signaling molecules and organizing specialized domains known as lipid rafts (Source: Biochimica et Biophysica Acta). In various diseases, including cancer and neurodegenerative disorders, the lipid composition and physical properties of the membrane are often dysregulated, contributing to pathological signaling (Source: Trends in Molecular Medicine). Therapeutic targeting of these lipids, a field known as membrane-lipid therapy (MLT) or melitherapy, aims to modify membrane structure to regulate the activity of membrane-associated proteins (Source: Journal of Medicinal Chemistry). Additionally, many antimicrobial agents, such as daptomycin and amphotericin B, exert their effects by directly binding to and disrupting the lipid bilayers of bacteria and fungi, respectively (Source: StatPearls). This target class is distinct from traditional protein targets as it relies on the physicochemical properties of the lipid environment rather than specific lock-and-key protein binding. However, achieving selectivity remains a challenge, as drugs must distinguish between the lipid compositions of pathogens and host cells to avoid systemic toxicity (Source: PubMed).
Drugs targeting membrane lipids typically act through direct physical disruption, such as the formation of transmembrane pores (e.g., polyenes) or detergent-like solubilization (e.g., polymyxins). Another major mechanism is the modulation of membrane physical properties—such as fluidity, thickness, and curvature—which in turn regulates the recruitment and activity of peripheral and integral membrane signaling proteins, a strategy referred to as membrane-lipid therapy (Source: Trends in Molecular Medicine).
8 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Lipid bilayer membrane lipids.